688428 諾誠健華
按盤價 
30.370 +0.160 (+0.530%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 731,434 | 74.26% | 1,009,448 | 738,537 | 625,404 | 1,043,033 | |
| 減：營業總成本 | 818,906 | 20.53% | 1,463,013 | 1,377,500 | 1,583,975 | 1,048,443 | |
| 其中:營業成本 | 76,713 | 27.56% | 138,441 | 128,435 | 143,397 | 65,667 | |
| 財務費用 | (46,054) | -9.53% | (93,762) | (68,906) | 171,321 | (188,911) | |
| 資產減值損失 | (141) | -- | (105) | -- | -- | -- | |
| 公允價值變動收益 | 4,943 | -121.25% | (30,462) | (53,963) | 9,953 | (44,281) | |
| 投資收益 | 20,805 | -2,330.69% | 7,117 | 5,572 | (1,225) | (534) | |
| 其中：對聯營企業和合營企業的投資收益 | (400) | -73.94% | (5,260) | (4,900) | (9,711) | (604) | |
| 營業利潤 | (30,885) | -88.47% | (451,049) | (651,154) | (893,202) | (21,461) | |
| 利潤總額 | (30,584) | -88.58% | (452,593) | (644,206) | (893,727) | (20,121) | |
| 減：所得稅費用 | 5,055 | 17,667.14% | 263 | 1,426 | -- | 46,558 | |
| 淨利潤 | (35,638) | -86.70% | (452,856) | (645,632) | (893,727) | (66,679) | |
| 減：非控股權益 | (5,547) | -9.24% | (12,223) | (14,369) | (7,134) | (2,133) | |
| 股東淨利潤 | (30,091) | -88.51% | (440,633) | (631,263) | (886,593) | (64,546) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.020 | -87.50% | -0.260 | -0.370 | -0.600 | -0.050 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 3.803 | -3.02% | 3.817 | 4.054 | 4.306 | 4.100 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 22/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
